As we saw in patients with diabetes, the accumulation of AF6 increased in patients with NAFLD in several databases, and the levels of AF6 appeared to gradually increase with NASH progression (Fig. 1a and Supplemental Fig. 1b). The gene discussed is AFDN; the disease is metabolic dysfunction-associated steatotic liver disease.